Dr. Patricia Delgado, MD
What this data tells you about Dr. Delgado
Dr. Patricia Delgado is a pathology - anatomic specialist in Coral Gables, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Delgado performed 4,385 Medicare services across 3,898 unique beneficiaries.
Between the years covered by Open Payments, Dr. Delgado received a total of $385 from 5 pharmaceutical and/or device companies across 9 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pathology - anatomic. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Delgado is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Florida License Status
FL DOH · MQA| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 74394 | Clear | January 31, 2028 | — |
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | 931 | $26 | $81 |
| Pap test, automated thin layer preparation; automated system and manual rescreening | 916 | $26 | $80 |
| Detection test by nucleic acid for human papillomavirus (hpv), high-risk types | 722 | $34 | $106 |
| Yeast/candida DNA test | 452 | $34 | $106 |
| Measurement of rna of bacteria in vaginal fluid specimen | 215 | $140 | $285 |
| Tissue pathology examination, moderate complexity | 210 | $54 | $286 |
| Cell examination of specimen, selective cellular enhancement technique | 184 | $52 | $276 |
| Tissue staining for diagnosis, initial | 90 | $76 | $266 |
| Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test | 80 | $34 | $106 |
| Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique | 77 | $34 | $106 |
| Detection test by nucleic acid for chlamydia trachomatis, amplified probe technique | 67 | $34 | $106 |
| Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), amplified probe technique | 67 | $34 | $106 |
| Tissue staining for diagnosis, additional | 57 | $64 | $205 |
| Detection test by nucleic acid for human papillomavirus (hpv), types 16 and 18 only | 53 | $39 | $122 |
| Microscopic genetic analysis of tumor, manual | 45 | $96 | $325 |
| Special stained specimen slides to examine tissue, each multiplex procedure | 44 | $137 | $325 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 39 | $270 | $1,267 |
| Detection test by nucleic acid for herpes simplex virus, amplified probe technique | 31 | $34 | $105 |
| Detection test by nucleic acid for multiple types of respiratory virus, multiple types or subtypes, 3-5 targets | 28 | $140 | $367 |
| Pap test | 25 | $16 | $75 |
| Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 21 | $74 | $300 |
| Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within | 18 | $24 | $50 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 13 | $50 | $184 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Delgado is a mixed practice specialist, with above-average Medicare volume (top 14% in FL), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Delgado experienced with screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision?
Does Dr. Delgado receive payments from pharmaceutical companies?
How do Dr. Delgado's costs compare to other pathology - anatomics in Coral Gables?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology